Cargando…

Delivering Two Tumour Antigens Survivin and Mucin-1 on Virus-Like Particles Enhances Anti-Tumour Immune Responses

Breast cancer (BC) is the most frequently diagnosed cancer in women, with many patients experiencing recurrence following treatment. Antigens delivered on virus-like particles (VLPs) induce a targeted immune response and here we investigated whether the co-delivery of multiple antigens could induce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campbell, Katrin, Young, Vivienne L., Donaldson, Braeden C., Woodall, Matthew J., Shields, Nicholas J., Walker, Greg F., Ward, Vernon K., Young, Sarah L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148150/ https://www.ncbi.nlm.nih.gov/pubmed/34066318 http://dx.doi.org/10.3390/vaccines9050463

Ejemplares similares

Adoptive cell therapy with CD4(+) T helper 1 cells and CD8(+) cytotoxic T cells enhances complete rejection of an established tumour, leading to generation of endogenous memory responses to non-targeted tumour epitopes
por: Li, Kunyu, et al.
Publicado: (2017)

Virus-Like Particles, a Versatile Subunit Vaccine Platform
por: Donaldson, Braeden, et al.
Publicado: (2014)

Dry Formulation of Virus-Like Particles in Electrospun Nanofibers
por: Dowlath, Sasheen, et al.
Publicado: (2021)

An Enhanced Heterologous Virus-Like Particle for Human Papillomavirus Type 16 Tumour Immunotherapy
por: Jemon, Khairunadwa, et al.
Publicado: (2013)

Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours.
por: Mogensen, O., et al.
Publicado: (1990)

Combining dendritic cells and B cells for presentation of oxidised tumour antigens to CD8(+) T cells
por: Grant, Melanie L, et al.
Publicado: (2017)

Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade
por: Altura, R A, et al.
Publicado: (2003)

Lack of evidence for MHC-unrestricted (atypical) recognition of mucin by mucinous pancreatic tumour-reactive T-cells
por: Selvan, R S, et al.
Publicado: (2000)

Oxidative stress specifically downregulates survivin to promote breast tumour formation
por: Pervin, S, et al.
Publicado: (2013)

Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome
por: Fangusaro, J R, et al.
Publicado: (2005)

HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
por: van den Ingh, H. F., et al.
Publicado: (1987)

The Frequency and Significance of Mucin in Sweat Gland Tumours
por: Lennox, B., et al.
Publicado: (1952)

Functionalisation of Virus-Like Particles Enhances Antitumour Immune Responses
por: Kramer, Katrin, et al.
Publicado: (2019)

Multi-target chimaeric VLP as a therapeutic vaccine in a model of colorectal cancer
por: Donaldson, Braeden, et al.
Publicado: (2017)

Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression
por: Krieg, A, et al.
Publicado: (2002)

Tumour antigenicity in ovarian cancer.
por: Levin, L., et al.
Publicado: (1975)

Anaphylactic tests for tumour antigen in transplantable animal tumours.
por: Dale, M. M.
Publicado: (1966)

Germline whole exome sequencing of a family with appendiceal mucinous tumours presenting with pseudomyxoma peritonei
por: Lung, Mei Sim, et al.
Publicado: (2020)

Mucinous ovarian tumour presenting as a ruptured incisional hernia
por: Toomey, D, et al.
Publicado: (2012)

Differentiating primary and extragenital metastatic mucinous ovarian tumours: an algorithm combining PAX8 with tumour size and laterality
por: Hu, Ajin, et al.
Publicado: (2015)

Radioimmunoassay of Tumour Specific Transplantation Antigen of a Chemically Induced Rat Sarcoma: Circulating Soluble Tumour Antigen in Tumour Bearers
por: Thomson, D. M. P., et al.
Publicado: (1973)

Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1
por: Suminami, Y, et al.
Publicado: (2000)

Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression.
por: Durrant, L. G., et al.
Publicado: (1987)

Decreased Gastric Gland Mucin-specific O-glycans Are Involved in the Progression of Ovarian Primary Mucinous Tumours
por: Ohya, Ayumi, et al.
Publicado: (2021)

Mannosylation of Virus-Like Particles Enhances Internalization by Antigen Presenting Cells
por: Al-Barwani, Farah, et al.
Publicado: (2014)

Particle Accelerators in Tumour Therapy
por: Amaldi, Ugo
Publicado: (2013)

Expression of nuclear survivin in normal skin and squamous cell carcinoma: a possible role in tumour invasion
por: Dallaglio, K, et al.
Publicado: (2014)

Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particles
por: Win, S J, et al.
Publicado: (2012)

Differentiation Between the Embryonic and Tumour Specific Antigens on Chemically Induced Rat Tumours
por: Baldwin, R. W., et al.
Publicado: (1974)

Defining stage in mucinous tumours of the appendix with peritoneal dissemination: the importance of grading terminology: systematic review
por: Martín-Román, L, et al.
Publicado: (2021)

Increased microvessel density in mucinous compared with malignant serous and benign tumours of the ovary.
por: Orre, M., et al.
Publicado: (1998)

Autoimmune responses to human tumour antigens.
por: Hodkinson, M., et al.
Publicado: (1969)

The isolation and characterization of tumour associated antigens.
por: Price, M. R., et al.
Publicado: (1974)

HNSCC: Tumour Antigens and Their Targeting by Immunotherapy
por: von Witzleben, Adrian, et al.
Publicado: (2020)

Advanced Antigen Delivery of Murine Survivin: Chimeric Virus-Like Particles in Cancer Vaccine Research
por: Schumacher, Thomas, et al.
Publicado: (2007)

Data on the uptake of reducible antigen-adjuvant conjugates by dendritic cells
por: Kramer, Katrin, et al.
Publicado: (2019)

Tumour Specific T-Like Antigen of Human Breast Carcinoma
por: Taylor, G., et al.
Publicado: (1970)

Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs
por: Iwasa, T, et al.
Publicado: (2010)

Specificity of tumour associated transplantation antigens (TATA) of different clones from the same tumour.
por: Woodruff, M. F., et al.
Publicado: (1984)

Effect of solubilized membrane antigens and tumour bearer serum on tumour growth in syngeneic hosts.
por: Forni, G., et al.
Publicado: (1974)

Cannot write session to /tmp/vufind_sessions/sess_tojoa30k2uf4unpq2o41t9gb9i